Non-Melanoma

Videos

Dr Schadendorf Discusses C.A.S.E. Study in CSCC; Current Treatment Changes

10/06/2020

Dirk Schadendorf, MD, discusses demographics, prior therapies and reasons for cemiplimab treatment for CSCC, and more.

Dirk Schadendorf, MD, discusses...

10/06/2020

Oncology

News

FDA Approves Pembrolizumab for Patients With Cutaneous Squamous Cell Carcinoma

06/24/2020

The FDA has approved pembrolizumab for the treatment of patients with recurrent or metastatic cutaneous squamous cell carcinoma incurable via surgery or radiation.

The FDA has approved...

06/24/2020

Oncology

News

Cemiplimab Therapy Safe, Active in Patients With Cutaneous Squamous Cell Carcinoma

02/05/2020

Study findings demonstrate the acceptable safety profile and antitumor activity of cemiplimab therapy for patients with locally advanced cutaneous squamous cell carcinoma.

Study findings demonstrate the...

02/05/2020

Oncology

Interview

First-Line Pembrolizumab Yields Robust Tumor Control, Favorable OS Over Chemo in Advanced MCC

02/13/2019

"Recent advances in our understanding of the human immune system and how it has the capacity to fight off and destroy cancer...has been nothing short of groundbreaking," says Dr Riker.

"Recent advances in our...

02/13/2019

Oncology